Stephen J. Tulipano
2016 - Aldeyra Therapeutics
In 2016, Stephen J. Tulipano earned a total compensation of $509.9K as Chief Financial Officer at Aldeyra Therapeutics, a 1% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $105,490 |
|---|---|
| Option Awards | $102,905 |
| Salary | $301,400 |
| Total | $509,894 |
Tulipano received $301.4K in salary, accounting for 59% of the total pay in 2016.
Tulipano also received $105.5K in non-equity incentive plan and $102.9K in option awards.
Rankings
In 2016, Stephen J. Tulipano's compensation ranked 11,110th out of 14,075 executives tracked by ExecPay. In other words, Tulipano earned more than 21.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,110 out of 14,075 | 21st |
Division Manufacturing | 4,314 out of 5,486 | 21st |
Major group Chemicals And Allied Products | 1,541 out of 1,900 | 19th |
Industry group Drugs | 1,243 out of 1,543 | 19th |
Industry Pharmaceutical Preparations | 964 out of 1,173 | 18th |
Source: SEC filing on April 24, 2017.
Tulipano's colleagues
We found three more compensation records of executives who worked with Stephen J. Tulipano at Aldeyra Therapeutics in 2016.